questionsmedicales.fr
Environnement et santé publique
Environnement
Concepts météorologiques
Atmosphère
Climat
Climat tropical
Climat tropical : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Climat tropical : Questions médicales les plus fréquentes",
"headline": "Climat tropical : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Climat tropical : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Climat tropical"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Climat",
"url": "https://questionsmedicales.fr/mesh/D002980",
"about": {
"@type": "MedicalCondition",
"name": "Climat",
"code": {
"@type": "MedicalCode",
"code": "D002980",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230.300.100.250"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Climat tropical",
"alternateName": "Tropical Climate",
"code": {
"@type": "MedicalCode",
"code": "D014329",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yadvinder Malhi",
"url": "https://questionsmedicales.fr/author/Yadvinder%20Malhi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant Biology, University of Illinois, Urbana, IL, USA."
}
},
{
"@type": "Person",
"name": "Hiroyuki Murakami",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Murakami",
"affiliation": {
"@type": "Organization",
"name": "Geophysical Fluid Dynamics Laboratory, National Oceanic and Atmospheric Administration, Princeton, NJ, USA."
}
},
{
"@type": "Person",
"name": "Erika Berenguer",
"url": "https://questionsmedicales.fr/author/Erika%20Berenguer",
"affiliation": {
"@type": "Organization",
"name": "Environmental Change Institute, School of Geography and the Environment, University of Oxford, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Fidèle Evouna Ondo",
"url": "https://questionsmedicales.fr/author/Fid%C3%A8le%20Evouna%20Ondo",
"affiliation": {
"@type": "Organization",
"name": "Agence Nationale des Parcs Nationaux, Libreville, Gabon."
}
},
{
"@type": "Person",
"name": "Sam Moore",
"url": "https://questionsmedicales.fr/author/Sam%20Moore",
"affiliation": {
"@type": "Organization",
"name": "Environmental Change Institute, School of Geography and the Environment, University of Oxford, Oxford, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37255478",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/jvi.00687-23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Subviral Dense Bodies of Human Cytomegalovirus Induce an Antiviral Type I Interferon Response.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36552792",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells11244028"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience.",
"datePublished": "2022-09-23",
"url": "https://questionsmedicales.fr/article/36211342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.905960"
}
},
{
"@type": "ScholarlyArticle",
"name": "Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells.",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36505400",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1050718"
}
},
{
"@type": "ScholarlyArticle",
"name": "Proximal protein landscapes of the type I interferon signaling cascade reveal negative regulation by PJA2.",
"datePublished": "2024-05-27",
"url": "https://questionsmedicales.fr/article/38802340",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-48800-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Environnement",
"item": "https://questionsmedicales.fr/mesh/D004777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Concepts météorologiques",
"item": "https://questionsmedicales.fr/mesh/D008685"
},
{
"@type": "ListItem",
"position": 5,
"name": "Atmosphère",
"item": "https://questionsmedicales.fr/mesh/D001272"
},
{
"@type": "ListItem",
"position": 6,
"name": "Climat",
"item": "https://questionsmedicales.fr/mesh/D002980"
},
{
"@type": "ListItem",
"position": 7,
"name": "Climat tropical",
"item": "https://questionsmedicales.fr/mesh/D014329"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Climat tropical - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Climat tropical",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Climat tropical",
"description": "Comment diagnostiquer une maladie liée au climat tropical ?\nQuels tests sont utilisés pour les infections tropicales ?\nQuels symptômes indiquent une maladie tropicale ?\nComment évaluer l'impact du climat tropical sur la santé ?\nQuelles sont les maladies endémiques dans les climats tropicaux ?",
"url": "https://questionsmedicales.fr/mesh/D014329?mesh_terms=Interferon+Type+I&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Climat tropical",
"description": "Quels sont les symptômes du paludisme ?\nComment reconnaître la dengue ?\nQuels symptômes sont associés à la fièvre jaune ?\nQuels signes indiquent une infection parasitaire ?\nComment se manifeste le chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D014329?mesh_terms=Interferon+Type+I&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Climat tropical",
"description": "Comment prévenir le paludisme ?\nQuelles mesures pour éviter la dengue ?\nComment se protéger contre la fièvre jaune ?\nQuelles sont les stratégies de prévention des infections parasitaires ?\nComment éviter le chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D014329?mesh_terms=Interferon+Type+I&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Climat tropical",
"description": "Quels traitements sont disponibles pour le paludisme ?\nComment traiter la dengue ?\nQuels médicaments sont utilisés pour la fièvre jaune ?\nComment traiter les infections parasitaires ?\nQuelles sont les options pour le chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D014329?mesh_terms=Interferon+Type+I&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Climat tropical",
"description": "Quelles complications peuvent survenir avec le paludisme ?\nQuels risques sont associés à la dengue sévère ?\nQuelles complications de la fièvre jaune sont possibles ?\nQuels problèmes peuvent résulter d'infections parasitaires ?\nQuelles complications sont liées au chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D014329?mesh_terms=Interferon+Type+I&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Climat tropical",
"description": "Quels sont les facteurs de risque du paludisme ?\nQui est le plus à risque de dengue ?\nQuels facteurs augmentent le risque de fièvre jaune ?\nQuels sont les risques d'infections parasitaires ?\nQui est le plus vulnérable au chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D014329?mesh_terms=Interferon+Type+I&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie liée au climat tropical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'historique de voyage et des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les infections tropicales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, des cultures et des examens microscopiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie tropicale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, éruptions cutanées, douleurs abdominales et fatigue sont des signes fréquents."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact du climat tropical sur la santé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études épidémiologiques et des analyses de données climatiques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les maladies endémiques dans les climats tropicaux ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme, la dengue et la fièvre jaune sont des exemples courants."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du paludisme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître la dengue ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, douleurs articulaires, éruptions cutanées et saignements légers."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la fièvre jaune ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs abdominales, jaunisse et saignements peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection parasitaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de poids, douleurs abdominales et troubles digestifs sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le chikungunya ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires sévères et éruptions cutanées sont typiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir le paludisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments prophylactiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la dengue ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des insecticides pour réduire les moustiques."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre la fièvre jaune ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est la meilleure protection contre la fièvre jaune."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de prévention des infections parasitaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une bonne hygiène, laver les aliments et éviter l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Comment éviter le chikungunya ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prévenir les piqûres de moustiques avec des vêtements longs et des répulsifs."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le paludisme ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antipaludiques comme la chloroquine et l'artémisinine sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment traiter la dengue ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique, mais le repos et l'hydratation sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour la fièvre jaune ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vaccin est le principal moyen de prévention, pas de traitement antiviral spécifique."
}
},
{
"@type": "Question",
"name": "Comment traiter les infections parasitaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiparasitaires comme l'albendazole ou le mébendazole sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour le chikungunya ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le paludisme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Anémie, défaillance organique et coma peuvent être des complications graves."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la dengue sévère ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Hémorragies, défaillance circulatoire et choc peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Quelles complications de la fièvre jaune sont possibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Insuffisance hépatique, hémorragies et décès peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Quels problèmes peuvent résulter d'infections parasitaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Malnutrition, troubles de croissance et complications immunitaires peuvent se produire."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées au chikungunya ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs articulaires persistantes et des complications neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du paludisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre ou voyager dans des zones endémiques, absence de protection contre les moustiques."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de dengue ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones urbaines tropicales et les voyageurs sont à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de fièvre jaune ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des zones endémiques sans vaccination augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'infections parasitaires ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conditions de vie insalubres, manque d'accès à l'eau potable et mauvaise hygiène."
}
},
{
"@type": "Question",
"name": "Qui est le plus vulnérable au chikungunya ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus vulnérables."
}
}
]
}
]
}
Studies already revealed that some E3 ubiquitin ligases participated in the immune response after viral infection by regulating the type I interferon (IFN) pathway. Here, we demonstrated that type I i...
(1) Background: Cells infected with the human cytomegalovirus (HCMV) produce subviral particles, termed dense bodies (DBs), both in-vitro and in-vivo. They are released from cells, comparable to infec...
Upregulation of type I interferon (IFN) signaling has been increasingly detected in inflammatory diseases. Recently, upregulation of the IFN signature has been suggested as a potential biomarker of IF...
The type I IFN signature was measured in patients' whole blood cells. Clinical and biological data were collected retrospectively, and an intensive genetic analysis was performed in undiagnosed patien...
A total of 117 samples from 94 patients with inflammatory diseases, including 37 undiagnosed cases, were analyzed. Increased IFN signaling was observed in 19 undiagnosed patients, with 10 exhibiting c...
Half of the patients examined in this study, with undifferentiated inflammatory diseases, clinically quiescent A20 haploinsufficiency, or idiopathic pulmonary hemosiderosis, had an elevated type I IFN...
Natural killer (NK) cells have an intrinsic ability to detect and eliminate leukaemic cells. Cellular therapies using cytokine-activated NK cells have emerged as promising treatments for patients with...
Deciphering the intricate dynamic events governing type I interferon (IFN) signaling is critical to unravel key regulatory mechanisms in host antiviral defense. Here, we leverage TurboID-based proximi...
The interferon score (IS) quantifies the expression of interferon-stimulated genes in peripheral blood, providing an indirect estimate of interferon-mediated inflammation in rheumatological disorders....
All patients referred to the Rheumatology Service of the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy, with a diagnosis of JIA (2001 ILAR criteria) were consecutively r...
Forty-four patients were recruited (35 F, 9 M): 19 polyarticular, 13 oligoarticular, 6 oligoarticular-extended, 5 psoriatic and 1 enthesitis-related arthritis. Sixteen had a positive IS (≥3). Increase...
Although based on a small case series, our results may support the role of IS in better defining a subgroup of JIA subjects with stronger autoimmune features. The possible relevance of these results f...
Evaluation of type I interferons (IFNs) in inflammatory or autoimmune diseases is challenging because of their rapid clearance in peripheral blood. The IFN gene expression signature has recently been ...
Data from flow cytometric analysis of surface CD169 on monocytes and an enzyme-linked immunosorbent assay of soluble CD169 in peripheral blood were compared with serum IFN-α levels in 8 patients with ...
Surface CD169 expression was detected mainly on CD14...
Analysis of CD169 expression on CD14...
Host immunity to infection with SARS-CoV-2 is highly variable, dictating diverse clinical outcomes ranging from asymptomatic to severe disease and death. We previously reported reduced type I interfer...
Down syndrome (DS) is typically caused by triplication of chromosome 21. Phenotypically, DS presents with developmental, neurocognitive, and immune features. Epidemiologically, individuals with DS hav...
Promyelocytic leukemia Nuclear Bodies (PML NBs) are nuclear membrane-less organelles physically associated with chromatin underscoring their crucial role in genome function. The H3.3 histone chaperone...